ZAP-70 and CD38 expression are independent prognostic factors in patients with B-cell chronic lymphocytic leukaemia and combined analysis improves their predictive value.

Iwona Hus, Agnieszka Bojarska-Junak, Anna Dmoszyńska, Ewa Wasik-Szczepanek, Małgorzata Sieklucka, Wioletta Trześniewska, Magdalena Glazer, Jacek Roliński
DOI: 10.2478/v10042-008-0022-7
·
Folia Histochem Cytobiol 2008;46(2):147-152.

open access

Vol 46, No 2 (2008)
Original Papers
Published online: 2008-06-04
Submitted: 2011-12-19

Abstract

Recently identified biological risk factors in B-cell chronic lymphocytic leukemia (B-CLL) include ZAP-70 and CD38 expression. The present study was conducted to clarify whether a combined analysis could improve predictive impact of these two parameters. We examined the expression of ZAP-70 and CD38 by flow cytometry method in 217 newly diagnosed, consecutive, unselected and well characterized B-CLL patients in relation to laboratory parameters and clinical outcome. We confirmed that both ZAP-70 as well as CD38 were independent of prognostic factors. There was a significant correlation between the percentage of leukemic cells positive for ZAP-70 and the percentage of CD38+CD19+ cells (R=0.629; p=0.000001). Combined analysis of ZAP-70 and CD38 showed concordant results in 158/217 patients (72.8%), while in 59 patients the results were discordant (27.2%). A mean treatment free survival (TFS) was the longest in ZAP-70-CD38-patients (45.6 months, comparing to 13.6 months in ZAP-70+CD38+ group). Also a mean overall survival was the longest in ZAP-70-CD38- patients (224.7 months compared to 77.9 months in ZAP-70+CD38+ patients).
About this article
Title

ZAP-70 and CD38 expression are independent prognostic factors in patients with B-cell chronic lymphocytic leukaemia and combined analysis improves their predictive value.

Journal

Folia Histochemica et Cytobiologica

Issue

Vol 46, No 2 (2008)

Pages

147-152

Published online

2008-06-04

DOI

10.2478/v10042-008-0022-7

Bibliographic record

Folia Histochem Cytobiol 2008;46(2):147-152.

Authors

Iwona Hus
Agnieszka Bojarska-Junak
Anna Dmoszyńska
Ewa Wasik-Szczepanek
Małgorzata Sieklucka
Wioletta Trześniewska
Magdalena Glazer
Jacek Roliński

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail:  viamedica@viamedica.pl